BridgeMD
New treatment option for Dry Eye Syndromes
Official title Protecting the Eyes of Gamers With Lubricating Eyedrops
ClinicalTrials.gov ID: NCT06163989
What this study is testing
What is TheaLoz Duo Eyedrop?
TheaLoz Duo Eyedrop is an investigational medicine, being studied as a potential treatment for dry eye syndromes.
Also referred to as Treatment Eyedrop.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The excessive use of screens particularly amongst digital gamers can adversely impact the health of the surface of the eyes with symptoms and signs of surface damage. While strategies including limiting screen time exist, these may be ineffective given the widespread rise of digital device use and gaming culture in the modern era.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Individuals with dryness symptoms as assessed with the Ocular Surface Disease Index (OSDI score ≥ 13).
- Individuals who play handheld console and computer-based games ≥ 2 hours everyday on average
- Individuals who are comfortable and competent at using smartphone applications
- Age ≥ 18 years, male or female
- Able to provide written consent in English
You likely can't join if
- Pregnancy
- Use of any topical ocular medical eyedrops or lubricants in the 1 week prior to starting the study or during the study period. Those who are using...
- History of ocular surgery, trauma or infections in the past 6 months
See the full eligibility criteria
- Individuals with dryness symptoms as assessed with the Ocular Surface Disease Index (OSDI score ≥ 13).
- Individuals who play handheld console and computer-based games ≥ 2 hours everyday on average
- Individuals who are comfortable and competent at using smartphone applications
- Age ≥ 18 years, male or female
- Able to provide written consent in English
- Able to instil the treatment lubricating eyedrop on their own, and return any provided eyedrop bottle to the researcher used at the end of the treatment
- Able to attend multiple visits (3 visits over 2 months)
- Pregnancy
- Use of any topical ocular medical eyedrops or lubricants in the 1 week prior to starting the study or during the study period. Those who are using existing lubricating eyedrops and are interested in participating will...
- History of ocular surgery, trauma or infections in the past 6 months
The study team makes the final eligibility decision.
Where it's taking place
- Birmingham, West Midlands, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Birmingham, West Midlands, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.